CDER’s Sequestration Strategy Aided By 400 Missing FTEs
FDA’s ability to avoid furloughs under sequester is not good news, OND Director John Jenkins says, but instead is a sign of severe understaffing that already existed.
FDA’s ability to avoid furloughs under sequester is not good news, OND Director John Jenkins says, but instead is a sign of severe understaffing that already existed.